SCIEQ1
Molecular Therapy Nucleic Acids
CELL PRESS
Molecular Therapy Nucleic Acids is an academic journal published by CELL PRESS. Identifiers: ISSN 2162-2531, eISSN 2162-2531. Indexed in SCIE. Metrics: JIF 6.1. Subject areas: MEDICINE, MEDICINE, RESEARCH & EXPERIMENTAL, RESEARCH & EXPERIMENTAL. tlooto lists 3,733 papers from this journal.
CiteScore
-
Scopus citation metric
SJR
-
SCImago rank
SNIP
-
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2162-2531
- eISSN
- 2162-2531
- Abbreviation
- MOL THER NUCL ACIDS
- Publisher
- CELL PRESS
- Country
- -
Web of Science categories
SCIEMEDICINE, RESEARCH & EXPERIMENTAL
Scopus ASJC categories
No ASJC category data available.
Keywords
Medicine, Research & Experimental
Papers in this journal
Recent papers
- A versatile VLP-mediated CRISPR-RNP platform for precise genome editing and durable epigenome silencing in cancer
2026
- Selective silencing of expanded CAG repeats: Chemically modified siRNA advances RNA-based therapies for polyglutamine diseases.
2026
- mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cells
2026 · 3 citations
- Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1A
2026 · 2 citations
- Exon-targeted U1 snRNA rescues splicing defects and ameliorates inherited optic neuropathy: A novel RNA-based treatment.
2026
Most cited papers
- Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
2015 · 1,118 citations
- siRNA Versus miRNA as Therapeutics for Gene Silencing
2015 · 974 citations
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
2019 · 739 citations
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
2017 · 698 citations
- Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
2012 · 612 citations